Funding & Investment

Hamilton Global Opportunities will spotlight the trend of retail access to private equity at an upcoming investor event, highlighting its role as a gateway.

In a tough climate, STG's rapid Allegro II fundraise shows insatiable investor appetite for enterprise software and faith in its operational playbook.

A massive $125M investment empowers five international teams to pursue radical ideas, from cancer-proof people to self-destructing tumors.

As probation and parole agencies buckle under pressure, Securus Monitoring showcases an AI-driven ecosystem aimed at easing burdens and aiding rehabilitation.

Named a top employer, Hydro Ottawa is redefining engineering careers with unique training and career paths to build a sustainable, net-zero grid.

CrossCountry Consulting's major acquisition of CNM LLP signals a bold West Coast expansion and a move to dominate the Office of the CFO advisory market.

With a new $300M fund, the Detroit PE firm hires three principals to accelerate its 'Fix and Build' strategy in lower middle-market manufacturing.

An Atlanta clinic combines lasers, biologics, and AI to challenge traditional joint surgery. Can a new marketing push make it a national alternative?

The 155-year-old snack maker updates its beloved animal crackers with a new name, healthier recipe, and a mission to boost children's reading skills.

A new report reveals 87% of firms use AI in customer education, but a dangerous lack of strategy and governance threatens quality, security, and ROI.

The private equity firm's carve-out of the world's largest coworking franchisor signals a major push to scale flexible workspaces for the hybrid era.

The AI firm reports a major financial overhaul and key acquisitions, but faces declining revenue and operational losses. Is it poised for a 2026 rebound?

Consark.ai's new Noa platform uses autonomous agents to execute complex accounting, promising a shift from human preparation to AI-led execution.

New data reveals Vermont's long-term care costs are among the nation's highest, forcing families and policymakers to confront a growing financial crisis.

A three-year private equity partnership transforms a family utility firm, culminating in a $276M sale to MasTec and signaling big moves in U.S. water infrastructure.

A next-gen drug for chronic hives shows superior, faster results than the long-standing standard of care, heralding a potential shift in allergy treatment.

VALR Brand hires Celsius veteran Bryan Alesiano as CRO, betting his Midas touch and their nitro-infused drinks can disrupt the competitive energy market.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

Shabodi's platform will power GMS's global aggregation strategy, accelerating the adoption of standardized APIs and a new era of programmable networks.

PenFed Foundation's latest accelerator cohort showcases veteran entrepreneurs tackling everything from national security to healthcare with military precision.